LAUNCHHUB
Live / Applied — Second extension granted (statement of use) (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 26 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98521217
- Mark type
- Stylized text
- Filed
- 26 Apr 2024
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Bobby A. Ghajar
Goods and services
- Class 040 — Treatment of materials: Biomanufacturing for others, namely, manufacturing of biopharmaceuticals using biological organisms in the manufacturing process
- Class 042 — Scientific and technological services: Testing, research, and development of biopharmaceutical preparations for cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell therapy; scientific research services, clinical research, and pre-clinical research in the field of cell therapy; consulting services in the fields of biopharmaceutical research and development and genetic science
Owner
- Cellares Corporation, South San Francisco, CA, US
- Cellares Corporation, South San Francisco, CA, US
Prosecution history
- 11 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — SOU EXTENSION 2 GRANTED
- 11 Mar 2026 — SOU EXTENSION 2 FILED
- 11 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2025 — SOU EXTENSION 1 GRANTED
- 08 Aug 2025 — SOU EXTENSION 1 FILED
- 08 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE